Search Results 171-180 of 17012 for pharmacogenetics
About this study. The purpose of this study is for The Center for Individualized Medicine (CIM) at Mayo Clinic to discover and translate genomic and ...
The American Heart Association gives guidance on CYP2C19 genetic-guided testing for prescribing blood thinner drugs. A Mayo Clinic cardiologist chaired the ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Genetic Testing in Screening Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial).
This study is being conducted to determine gene and protein expression profiles (i.e. which genes and proteins are turned off and on) of those with a ...
https://www.nimh.nih.gov/health/topics/mental-health-medications#part_2364. Accessed July 29, 2024. Sreeja V, et al. Pharmacogenetics of selective serotonin ...
This diagram illustrates epigenetic writers, readers and erasers of histone H3 lysine 36 methylation, their links to human disease and cancer, ...
See posters, presentations and video from Dr. Ertekin-Taner's Genetics of Alzheimer's Disease and Endophenotypes Lab at Mayo Clinic's campus in Florida.
Replacing these genes with healthy genes may help treat certain diseases. For example, a gene called p53 usually prevents tumor growth. Several types of cancer ...
About this study. The purpose of this study is to use genomic and proteomic analyses to identify possible diagnostic markers and potential drugs for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.